45
Participants
Start Date
April 30, 2025
Primary Completion Date
December 30, 2027
Study Completion Date
September 30, 2028
EscharEx (EX-03)
a sterile lyophilized powder containing a concentrate of proteolytic enzymes enriched in bromelain (anacaulase-bcdb). The powder and sterile water are mixed to form a gel prior to application on the wound area.
Placebo (Gel vehicle)
A sterile powder containing excipients only (no proteolytic enzymes). The powder and sterile water are mixed to form a gel prior to application on the wound area
ILD Research Center, Carlsbad
Wojskowy Instytut Medyczny, Warsaw
Lead Sponsor
MediWound Ltd
INDUSTRY